FdaApplication
ANDA 202519
Identifiers
- fda_app_no: ANDA202519
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2013-03-21 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;160MG | TABLET;ORAL |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;80MG | TABLET;ORAL |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 25MG;320MG | TABLET;ORAL |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 25MG;160MG | TABLET;ORAL |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;320MG | TABLET;ORAL |
5 products